Tag Archives: pharmaceutical

Glial Cell Line Derived Neurotrophic Factor Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 15, 2017:  Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report “Glial Cell Line Derived Neurotrophic Factor – Pipeline Review, H2 2017”, outlays comprehensive information on the Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324458

Epstein-Barr Virus (HHV-4) Infections Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 14, 2017:  Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide “Epstein-Barr Virus Infections – Pipeline Review, H2 2017”, provides an overview of the Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline landscape.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324473

Epstein-Barr virus (EBV), also known as human herpesvirus 4, is a member of the herpes virus family. It is one of the most common human viruses. EBV spreads most commonly through bodily fluids. EBV can also spread through blood and semen during sexual contact, blood transfusions, and organ transplantations. Symptoms of EBV infections include fatigue, fever, and inflamed throat, swollen lymph nodes in the neck, enlarged spleen, swollen liver and rash.

Ebolavirus Infections (Ebola Hemorrhagic Fever) Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 15, 2017:  Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide “Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H2 2017”, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline landscape.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324471

Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids and pain relievers.

Report Highlights

Deep Vein Thrombosis (DVT) Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 15, 2017:  Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide “Deep Vein Thrombosis – Pipeline Review, H2 2017”, provides an overview of the Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline landscape.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324466

Deep venous thrombosis is a blood clot that forms in a vein deep inside a part of the body. It mainly affects the large veins in the lower leg and thigh. Symptoms include changes in skin color (redness), leg pain, leg swelling (edema) and skin that feels warm to the touch. The predisposing factors include age, smoking, inheriting a blood-clotting disorder, injury or surgery, cancer, inflammatory bowel disease and heart failure. Treatment includes thrombolytic and anticoagulants.

CD40 Ligand Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 14, 2017:  CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) – CD40 ligand or CD40L is a protein that is primarily expressed on activated T cells and is a member of the TNF superfamily. “CD40 Ligand Pipeline Review, H2 2017” The CD40-CD40 ligand interaction is crucial to the development of T dependent immune responses.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324456

Arterial Thrombosis Pipeline Insight and Therapeutic Assessment Reviewed in 2017

Albany, New York, Sep 15, 2017:  Market Research Hub’s latest Pharmaceutical and Healthcare disease pipeline guide “Arterial Thrombosis – Pipeline Review, H2 2017”, provides an overview of the Arterial Thrombosis (Cardiovascular) pipeline landscape.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324465

Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension and high cholesterol level. Treatment includes thrombolytic agents and surgery.

Asia-Pacific Direct Thrombin Inhibitor Market Report : Share, Growth, Size, Trends and Forecast 2017 – 2022

Albany, New York, Sep 14, 2017:  To Understand the Pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Asia-Pacific Direct Thrombin Inhibitor Market Report”, to its vast database. This study offers data about the prime regions operating in the Pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until 2022.

Request For Free Sample – http://www.marketresearchhub.com/enquiry.php?type=S&repid=1316264

Global Medical Adhesive Tapes Market In Japan, 2017 To 2022: By Resin Type – Acrylic, Silicone, Rubber & Others

Researchmoz added Most up-to-date research on “Global Medical Adhesive Tapes Market In Japan, 2017 To 2022: By Resin Type – Acrylic, Silicone, Rubber & Others” to its huge collection of research reports.

The global Medical Adhesive Tapes market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

Increasing Need Of Allergy Treatment In Global Market: Size, Share, Growth, Trends, and Forecast, 2017 – 2025

Researchmoz added Most up-to-date research on “Increasing Need Of Allergy Treatment In Global Market: Size, Share, Growth, Trends, and Forecast, 2017 – 2025” to its huge collection of research reports.

The allergy treatment market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on new treatment development for allergy specific drugs, and increasing prevalence of allergic diseases. The market overview section of the report comprises qualitative analysis of the overall allergy treatment market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, market opportunity analysis for product for global as well as Asia Pacific has also been provided. The report also comprises prevalence of allergy by type, and by region.

Designed by CyFocus.com
Powered by CyFocus.net